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Endonuclease III is a bifunctional DNA glycosylase that removes a wide range
of oxidized bases in DNA. Deinococcus radiodurans is an extreme radiation-
resistant and desiccation-resistant bacterium and possesses three genes
encoding endonuclease III enzymes in its genome: DR2438 (EndoIII-1),
DR0289 (EndoIII-2) and DR0982 (EndoIII-3). Here, EndoIII-1 and an
N-terminally truncated form of EndoIII-3 (EndoIII-376) have been expressed,
puriﬁed and crystallized, and preliminary X-ray crystallographic analyses have
been performed to 2.15 and 1.31 A˚ resolution, respectively. The EndoIII-1
crystals belonged to the monoclinic space group C2, with unit-cell parameters
a = 181.38, b = 38.56, c = 37.09 A˚,  = 89.34 and one molecule per asymmetric
unit. The EndoIII-376 crystals also belonged to the monoclinic space group
C2, but with unit-cell parameters a = 91.47, b= 40.53, c= 72.47 A˚, = 102.53 and
one molecule per asymmetric unit. The EndoIII-1 structure was determined
by molecular replacement, while the truncated EndoIII-376 structure was
determined by single-wavelength anomalous dispersion phasing. Reﬁnement of
the structures is in progress.
1. Introduction
Deinococcus radiodurans is an extremophilic bacterium that is able
to withstand high doses of ionizing radiation, which introduce many
diverse lesions into the DNA, including lethal double-strand breaks
but also numerous base modiﬁcations such as alkylation, oxidation
and deamination (Sutherland et al., 2000; Ward, 1988). Many factors
could contribute to the innate resistance of D. radiodurans to DNA
damage, such as a high genome copy number (between four and ten
copies during the exponential phase of growth) and an efﬁcient
DNA-repair pathway (Battista, 1997).
Repair of base modiﬁcations is carried out by the base excision
repair (BER) pathway (Krokan & Bjøra˚s, 2013). The pathway is
initiated by DNA glycosylases, which recognize the damaged bases
and remove them by hydrolyzing the N-glycosidic bond between the
base and the sugar phosphate backbone, thereby generating an abasic
site. The next step is performed by apurinic (AP) endonucleases,
DNA polymerases and DNA ligases. Some of the DNA glycosylases
are bifunctional and contain an AP lyase activity in addition to their
N-glycosidic activity and are not dependent upon the lyase activity
of AP endonucleases or DNA polymerases in order to complete the
repair.
This is the case for endonuclease III (EndoIII) enzymes, a family of
bifunctional DNA glycosylases that recognize and remove oxidized
pyrimidines, such as thymine glycol, from damaged DNA. These
enzymes are highly conserved throughout the three kingdoms of life.
Unlike most other organisms, the genome of D. radiodurans encodes
an expanded number of DNA glycosylases, including three endo-
nuclease III enzymes (named EndoIII-1, EndoIII-2 and EndoIII-3).
EndoIII-1 corresponds to the protein encoded by gene DR2438,
EndoIII-2 to that encoded by DR0289 and EndoIII-3 to that encoded
by DR0928 (Makarova et al., 2001). Our sequence alignment analyses
reveal that EndoIII-1 shares 30 and 32% sequence identity with
EndoIII-2 and EndoIII-3, respectively, and EndoIII-2 and EndoIII-3
share 34% sequence identity. D. radiodurans EndoIII-2 displays the
highest similarity to Escherichia coli EndoIII, sharing 43% sequence
identity.
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N-terminally truncated EndoIII-3 (EndoIII-376) and full-length
EndoIII-1 were cloned, expressed, puriﬁed and crystallized. Structure
determination of these enzymes will contribute to a better under-
standing of the unusual DNA repair repertoire and outstanding
radiation-resistance phenotype of D. radiodurans.
2. Materials and methods
2.1. Sequence amplification and cloning
The gene encoding EndoIII-1 (residues 1–259) was ampliﬁed by
PCR and cloned into pDest14 (Invitrogen), and a noncleavable
N-terminal hexahistidine tag (encoded by the PCR primers) was
inserted upstream of the gene (Table 1). A construct corresponding
to an N-terminally truncated form of EndoIII-3 (EndoIII-376)
lacking the nonconserved N-terminal region (residues 1–75) was
cloned into pDest14 (Invitrogen) and both an N-terminal hexa-
histidine tag and a TEV protease cleavage site (encoded by the PCR
primers) were inserted upstream of the gene, as described previously
(Moe et al., 2012; Table 1).
2.2. Protein expression
Plasmids encoding EndoIII-1 and EndoIII-376 were transformed
into E. coli strain BL21 (DE3) pLysS (Table 1). Cells were grown
in LB (lysogeny broth) medium with 100 mg ml1 ampicillin and
34 mg ml1 chloramphenicol. Overnight precultures were grown at
310 K and used to inoculate a 1 l culture. Cultures were grown at
310 K until the OD600 reached 0.7–0.9. Expression was induced with
0.5 mM isopropyl -d-1-thiogalactopyranoside (IPTG) at 293 K
overnight. Cells were harvested by centrifugation at 7548g for 25 min
and resuspended in 20 ml buffer 1 (150 mM NaCl, 50 mM Tris–HCl
pH 7.5) for EndoIII-1 or 20 ml buffer 2 (150 mM NaCl, 50 mM Tris–
HCl pH 8.5) for EndoIII-376, and were then ﬂash-frozen and stored
at 253 K. Cells were lysed by multiple freeze–thaw cycles (alternating
298 K water bath and liquid nitrogen) in the presence of lysozyme
and DNaseI. Protease-inhibitor tablets (Roche) were included in the
lysis buffers. The lysates were cleared by centrifugation at 48 385g for
25 min at 277 K and the supernatants were carefully removed and
used for subsequent chromatography steps.
2.3. EndoIII-1 purification and crystallization
Supernatant containing EndoIII-1 was loaded onto 1 ml Superﬂow
Ni–NTA (Qiagen) resin pre-equilibrated in buffer 1. The resin was
then washed with buffer 1, buffer 1 containing 1M NaCl and buffer
1 supplemented with 25 mM imidazole before eluting EndoIII-1 with
a linear 25–500 mM imidazole gradient. The purity of the fractions
was analysed by SDS–PAGE and the peak fractions were pooled and
concentrated to 11.8 mg ml1.
Initial crystallization screening was performed at 293 K by sitting-
drop vapour diffusion in Greiner CrystalQuick plates. A Cartesian
PixSys 4200 crystallization robot (High Throughput Crystallization
Laboratory at EMBL Grenoble) was used in order to test 576
different crystallization conditions (using the method described in
Dimasi et al., 2007). The following commercial screens (Hampton
Research) were set up: Crystal Screen, Crystal Screen 2, Crystal
Screen Lite, PEG/Ion, MembFac, Natrix, Quick Screen, Grid Screens
(Ammonium Sulfate, Sodium Malonate, Sodium Formate, PEG 6K,
PEG/LiCl, MPD) and Index. Crystals were obtained in several
conditions and the most promising ones, from the Index screen, were
used as a starting point for manual optimization using the hanging-
drop method at 293 K. Crystals of EndoIII-1 were grown in droplets
consisting of 1 ml protein solution (at both 5.8 and 11.8 mg ml1) and
1 ml reservoir solution after 1–2 d of equilibration against 500 ml
reservoir in the well. Crystals giving the best diffraction data were
obtained directly from Index screen condition No. 34 [1.0M succinic
acid pH 7.0, 0.1M HEPES pH 7.0, 1%(w/v) PEG MME 2000] at
293 K (Table 2).
2.4. EndoIII-3D76 purification and crystallization
Supernatant containing EndoIII-376 was loaded onto 1 ml
Superﬂow Ni–NTA (Qiagen) resin pre-equilibrated in buffer 2. The
resin was then washed with buffer 2, buffer 2 containing 1M NaCl
and buffer 2 supplemented with 40 mM imidazole before eluting
crystallization communications




Source organism D. radiodurans R1 D. radiodurans R1
DNA source Genomic DNA Genomic DNA
Expression vector pDest14 (N-terminal His tag encoded by the forward PCR primer) pDest14 (N-terminal His tag and TEV cleavage site encoded by the
forward PCR primer)
Expression host E. coli strain BL21 (DE3) pLysS E. coli strain BL21 (DE3) pLysS
Complete amino-acid sequence















Method Hanging-drop vapour diffusion Hanging-drop vapour diffusion
Plate type 24-well plate 24-well plate
Temperature (K) 293 293
Protein concentration (mg ml1) 5.8 and 11.8 6 and 12
Buffer composition of protein solution 0.05M Tris–HCl pH 7.5, 0.15M NaCl, 0.2M imidazole 0.05M Tris–HCl pH 8.5, 0.15M NaCl
Composition of reservoir solution 1.0M succinic acid pH 7.0, 0.1M HEPES pH 7.0,
1%(w/v) PEG MME 2000
0.1M MES pH 6.5, 1.4M ammonium sulfate,
0.01M cobalt(II) chloride hexahydrate
Volume and ratio of drop 1 ml protein solution + 1 ml reservoir solution 2 ml protein solution + 2 ml reservoir solution
Volume of reservoir (ml) 500 500
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EndoIII-376 with buffer 2 containing 250 mM imidazole. The
protein solution was dialyzed overnight at 277 K to remove the
imidazole and at the same time TEV protease was added [1:30(w:w)]
to cleave off the His tag. The protein solution was then applied onto
the same Ni–NTA gravity-ﬂow column to remove the cleaved His tag
and the His-tagged TEV protease. The cleaved protein showed some
intrinsic afﬁnity for the resin and had to be eluted with buffer 2
containing 25 mM imidazole. The ﬂowthrough and low-imidazole
wash fractions were then pooled and concentrated using a 10 kDa
cutoff ﬁlter spin column (Amicon) until a volume of 1–2 ml was
reached with a yield of 11–15 mg. The protein was then diluted in
buffer 2 with 75 mMNaCl to reduce the salt concentration to 100 mM
before ion-exchange chromatography on a Mono S column (GE
Healthcare). The enzyme was eluted with a linear salt gradient from
0 to 0.4M NaCl. The peak fractions were pooled, concentrated and
loaded onto a Superdex 75 10/300 size-exclusion column (GE
Healthcare) equilibrated with buffer 2. The protein was concentrated
to 12 mg ml1 and stored at 193 K. The purity, as judged by SDS–
PAGE analysis, was estimated to be greater than 95%.
The ﬁrst crystallization hits for EndoIII-376 were obtained from
commercial screens (Crystal Screen and Crystal Screen 2, Hampton
Research) using the hanging-drop vapour-diffusion method in 24-well
plates at 293 K. The best crystals were obtained in condition No. 25
of Crystal Screen 2 [0.1M MES pH 6.5, 1.8M ammonium sulfate,
0.01M cobalt(II) chloride hexahydrate]. These crystals were opti-
mized manually and diffraction-quality crystals were obtained in
drops consisting of 2 ml precipitation solution [0.1M MES pH 6.5,
1.4M ammonium sulfate, 0.01M cobalt(II) chloride hexahydrate]
with 2 ml protein at 6 and 12 mg ml1 (Table 2). The crystals grew
within 2 d to rectangular cuboids with dimensions of 0.2  0.1 
0.1 mm. Crystals were mounted in cryoloops and soaked in crystal-
lization solution with 30% sucrose as a cryoprotectant before ﬂash-
cooling them in liquid nitrogen.
2.5. EndoIII-1 X-ray diffraction analysis and structure determination
EndoIII-1 data were collected on the tunable beamline ID23-1 at
the European Synchrotron Radiation Facility (ESRF), Grenoble
using an ADSC detector at 100 K (Table 3). A ﬂuorescence scan was
performed to localize the peak energy of the absorption edge of the
native iron–sulfur cluster to optimize the recording of anomalous
signal. The structure of EndoIII-1 was solved with one data set
collected at the peak energy of the iron (7.1476 keV, wavelength
1.735 A˚) to a maximum resolution of 1.6 A˚. The data set was inte-
grated with XDS (Kabsch, 2010) and scaled with SCALA (Evans,
2006). The EndoIII-1 crystals belonged to the monoclinic space group
C2, with unit-cell parameters a = 181.38, b = 38.56, c = 37.09 A˚,
 = 90.00, = 89.34,  = 90.00, one molecule per asymmetric unit and
a solvent content of 45.2% (Table 4). The crystals suffered severe
radiation damage, so only the ﬁrst 400 of a total of 800 frames were
used for data processing and structure determination and the reso-
lution was cut back to 2.15 A˚. The structure was solved by molecular
replacement with MOLREP and Phaser using the E. coli endo-
nuclease III (PDB entry 2abk; Thayer et al., 1995) as a search model
(McCoy et al., 2007; Vagin & Teplyakov, 2010; Winn et al., 2011).
Phaser successfully built a complete chain including residues 13–247.
Further model building was performed using Coot and the structure is
being reﬁned in REFMAC5 using TLS parameters (Murshudov et al.,
2011; Winn et al., 2011).
2.6. EndoIII-3D76 X-ray diffraction analysis and structure
determination
EndoIII-376 data were also collected on ID23-1 at the ESRF
using an ADSC detector at 100 K (Table 3). The absorption edge of
the intrinsic iron–sulfur cluster was determined by a ﬂuorescence
scan to optimize the recording of anomalous signal. The structure of
EndoIII-376 was solved with one data set collected at the peak
crystallization communications




EndoIII-1 (peak) EndoIII-376 (peak) Data set 1 (low resolution) Data set 2 (high resolution)
X-ray source ESRF beamline ID23-1 ESRF beamline ID23-1 ESRF beamline ID23-1
Wavelength (A˚) 1.735 1.735 1.078
Temperature (K) 100 100 100
Detector ADSC Q315 ADSC Q315 ADSC Q315
Crystal-to-detector distance (mm) 105.1 111.1 244.0 144.0
Rotation range per image () 0.70 0.50 2.25 1.40
Total rotation range () 560 720 472.5 336
Exposure time per image (s) 0.7 0.1 0.1 0.1
Table 4
Data statistics.
Values in parentheses are for the outer shell.
EndoIII-1 (peak) EndoIII-376 (peak) EndoIII-376 (remote)
Space group C2 C2 C2
a, b, c (A˚) 181.38, 38.56, 37.09 91.47, 40.53, 72.47 91.24, 40.21, 72.15
, ,  () 90.0, 89.3, 90.0 90.0, 102.5, 90.0 90.0, 102.3, 90.0
No. of molecules in unit cell 1 1 1
Solvent content (%) 45.2 44.5 44.5
Resolution range (A˚) 45.34–2.15 (2.27–2.15) 42–1.90 (2.00–1.90) 50–1.31 (1.34–1.31)
Total No. of reﬂections 78062 (11034) 281033 (39088) 413966 (7675)
No. of unique reﬂections 14192 (2026) 20669 (2973) 61009 (4115)
Completeness (%) 99.8 (99.4) 99.4 (98.4) 98.2 (90.2)
Anomalous completeness (%) 99.2 (98.6) 99.0 (97.0)
Multiplicity 5.5 (5.4) 13.6 (13.1) 6.8 (1.87)
hI/(I)i 12.7 (2.5) 39.1 (15.8) 17.40 (2.1)
Rmerge (%) 7.3 (79.4) 4.7 (15.5) 5.8 (30.2)
Overall B factor from Wilson plot (A˚2) 30.5 25.9 20.1
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energy of the iron (7.1476 keV, wavelength 1.735 A˚) and reﬁned
against a high-resolution native data set (merged data from a high-
resolution and a low-resolution pass) collected at a remote energy
(11.5 keV, wavelength 1.078 A˚) from a second crystal (Table 3). The
EndoIII-376 crystals belonged to the monoclinic space group C2,
with unit-cell parameters a = 91.47, b = 40.53, c = 72.47 A˚,  = 90.00,
 = 102.53,  = 90.00, one molecule per asymmetric unit and
a solvent content of 44.5% (Table 4). Data sets were integrated with
XDS and then scaled with XSCALE (Kabsch, 2010). Phasing and
initial model building were performed using the automated SAS
protocol of Auto-Rickshaw (the EMBL Hamburg automated crystal
structure-determination platform; Panjikar et al., 2005). The input
diffraction data were prepared and converted for use in Auto-
Rickshaw using programs from the CCP4 suite (Winn et al., 2011).
Based on an initial analysis of the data, the maximum resolution for
substructure determination and initial phase calculation was set to
1.90 A˚. All four of the heavy-atom positions requested were found
using SHELXD (Sheldrick, 2010). The correct hand for the
substructure was determined using ABS (Hao, 2004) and SHELXE
(Sheldrick, 2010). Initial phases were calculated after density modi-
ﬁcation using SHELXE (Sheldrick, 2010). 88% of the model was
built using ARP/wARP (Langer et al., 2008). The resulting model
consisted of a polypeptide made up of glycine, alanine and serine
residues. Further model building was performed using ARP/wARP
(Langer et al., 2008) with the correct sequence ﬁle, and reﬁnement of
the structure against the high-resolution data set (1.31 A˚) is under
way.
3. Results and discussion
In this study, we have successfully established expression, puriﬁcation
and crystallization conditions for two of the three forms of EndoIII
from D. radiodurans. In the case of EndoIII-1 the intact gene was
expressed and puriﬁed to homogeneity, while for EndoIII-376 an
N-terminally deleted construct in which the nonconserved N-terminal
tail was removed was prepared, since the full-length protein was
poorly soluble and was very unstable during the various chromato-
graphic steps.
This new construct of EndoIII-3 was well expressed and the ﬁnal
yields for both EndoIII-376 and EndoIII-1 were very satisfactory at
>30 mg per litre of culture.
Both recombinant proteins contained a [4Fe–4S] cluster as judged
by the brownish colour of the concentrated protein solutions and by
their characteristic absorption spectra displaying a peak at 410 nm
(Fig. 1).
Initial crystals were obtained for both of the proteins using
commercial screens. In the case of EndoIII-1, single crystals obtained
directly from the Index screen were used for diffraction experiments,
while for EndoIII-376 manual optimization was needed (Fig. 1).
Both precipitant and protein concentrations were varied so as to slow
the growth of the crystals and to obtain diffraction-quality crystals. In
the end, high-resolution data sets were collected from crystals of both
EndoIII-376 (1.31 A˚ resolution) and EndoIII-1 (2.15 A˚ resolution).
The EndoIII-376 crystals belonged to space group C2, with unit-cell
parameters a = 91.47, b = 40.53, c = 72.47 A˚,  = 90.00,  = 102.53,
 = 90.00, and the EndoIII-1 crystals belonged to space group C2,
with unit-cell parameters a = 181.38, b = 38.56, c = 37.09 A˚,  = 90.00,
 = 89.34,  = 90.00.
For phasing purposes, after carrying out a ﬂuorescence scan on the
tunable beamline ID23-1 at the ESRF, anomalous signal from the
iron was detected for crystals of both EndoIII enzymes, and two
complete SAD data sets were collected at the peak energy. In the case
of EndoIII-376, we collected an additional high-resolution data set
by combining data from a high-resolution and a low-resolution pass
collected at a remote energy (Table 3) to use for reﬁnement of the
structure. Interestingly, although these peak data sets were collected
in similar ways from relatively large crystals (Fig. 1), the EndoIII-1
crystals suffered from serious radiation damage and the resolution of
the ﬁnal data set was cut to 2.15 A˚. The structure of EndoIII-1 was
solved by molecular replacement using the E. coli endonuclease III as
a search model. In contrast, no clear molecular-replacement solutions
were obtained for EndoIII-376, so experimental SAD phasing
was performed using the automated Auto-Rickshaw platform. Final
model building and reﬁnement are ongoing for both these structures.
We expect these structures to provide us with clues as to why the
extremely radiation-resistant bacterium D. radiodurans possesses
three different forms of this essential BER enzyme.
The data for this work was collected on the ID23-1 beamline at the
ESRF. We thank the beamline staff for assistance and advice during
data collection. This work used the high-throughput crystallization
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CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-
02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Part-
nership for Structural Biology (PSB). This work was supported by
funding from the Research Council of Norway (Synkrotron Program,
Project No. 185269) and from the in-house research program of the
ESRF. Part of this work was also funded by the CEA in the context
of the ‘Radiations ionisantes’ programme and a Marie Curie Intra-
European Fellowship (IEF) for career development through FP7 of
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